Potential increased risk of death and serious adverse effects with cancer medicine Copiktra (duvelisib): USFDA Drug safety communication

Drug Safety Updates, Global Safety Alerts, Safety Communications, US-FDA, , ,

USFDA released a recent safety update for the duvelisib, which is used in the treatment of blood cancer – chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is a PI3 kinase inhibitor, which controls the multiplication and growth of cancer cells by blocking the signaling action of abnormal protein. After the product approval…

Read More

Drug Safety Alerts from New Zealand Health Authority

Drug Safety Alerts from New Zealand Health Authority-MedSafe

Drug Safety Alert, Drug Safety Updates, Global Safety Alerts, Medicinal Product Updates, Medsafe- New Zealand, Pharmacovigilance, Voluntary ADR reporting, , , , , , ,

MedSafe- Health Authority of New Zealand government has released the below drug safety information in their latest issue-June-2020 to update public-(health care professionals & consumers) about the safe use of medicines.   Tramadol use Contradicted in children & elder patients (<75 y) Oral cleft defects associated with ondansetron   Tramadol use Contradicted in children &…

Read More

error: Content is protected !!